Metastasis remains a critical challenge in cancer treatment and the leading cause of cancer-related mortality. Ongoing research has demonstrated the ...
Metastasis and disease progression remain the leading causes of mortality in both breast and cervical cancer. These processes ...
The field of tumor microenvironment research has increasingly highlighted the intertwined relationship between aberrant vasculature and dysregulated immune ...
Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
Why do some tumours spread while others remain localised? The mechanisms governing the metastatic potential of tumour cells remain largely unknown — yet understanding this is crucial for optimising ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
Adding elraglusib to chemotherapy significantly increases overall survival in patients with previously untreated metastatic PDAC.